The Uromigos
A podcast by The Uromigos
401 Episodes
-
Episode 21: Treating cancer patients over the next year in the era of COVID-19
Published: 4/15/2020 -
Episode 20: Treating GU Cancer Patients with acute COVID-19 Infection
Published: 4/15/2020 -
Episode 19: Professor Monty Pal discusses the treatment of non-clear cell renal cancer
Published: 4/15/2020 -
Episode 18: COVID-19: Addressing Renal Cancer Patients’ Concerns
Published: 4/6/2020 -
Episode 17: Dr. Toni Choueiri discusses cancer trials and meetings during COVID-19
Published: 4/2/2020 -
Episode 16: Treatments and Trials for COVID-19
Published: 3/31/2020 -
Episode 15: COVID-19 and Bladder Cancer Surgery
Published: 3/28/2020 -
Episode 14: A Discussion about Tocilizumab and COVID-19 with Dr. Nick Mark from Seattle
Published: 3/24/2020 -
Episode 13: COVID-19 and Hydroxychloroquinine Existing Data and Ongoing Trials
Published: 3/23/2020 -
Episode 12: COVID-19 in Cancer Patients - The Seattle Experience
Published: 3/20/2020 -
Episode 11: COVID-19 and Immune Checkpoint Inhibitors for the Treatment of Cancer
Published: 3/16/2020 -
Episode 10: COVID-19 and Renal Cancer: A Patient's Perspective
Published: 3/16/2020 -
Episode 9: COVID-19 and Cancer: An International Perspective
Published: 3/16/2020 -
Episode 8: COVID-19 and Cancer Patients
Published: 3/13/2020 -
Episode 7: The First Uromigos Prostate Cancer Podcast
Published: 2/27/2020 -
Episode 6: Urothelial Cancer Highlights from ASCO GU 2020
Published: 2/26/2020 -
Episode 5: Renal Highlights from ASCO GU 2020
Published: 2/24/2020 -
Episode 4: Treatment Choices in Front Line Advanced Renal Cancer
Published: 2/11/2020 -
Episode 1: Introduction to Uromigos Podcasts
Published: 2/11/2020 -
Episode 2: The Current role of IO in Front-line Advanced Urothelial Cancer
Published: 2/11/2020
Broadcasting the latest developments in GU cancer Hosted by Brian Rini and Tom Powles Brian Rini MD is a Professor of Cancer Research and Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London
